Abstract

The development of hepatocellular carcinoma (HCC) is an important complication of viral infection induced by hepatitis virus C, and our major research theme is to identify a new growth factor related to the progression of HCC. HDGF (hepatoma-derived growth factor) is a novel growth factor that belongs to a new gene family. HDGF was initially purified from the conditioned medium of a hepatoma cell line. HDGF promotes cellular proliferation as a DNA binding nuclear factor and a secreted protein acting via a receptor-mediated pathway. HDGF is a unique multi-functional protein that can function as a growth factor, angiogenic factor and anti-apoptotic factor and it participates in the development and progression of various malignant diseases. The expression level of HDGF may be an independent prognostic factor for predicting the disease-free and overall survival in patients with various malignancies, including HCC. Furthermore, the overexpression of HDGF promotes the proliferation of HCC cells, while a reduction in the HDGF expression inhibits the proliferation of HCC cells. This article provides an overview of the characteristics of HDGF and describes the potential role of HDGF as a growth-promoting factor for HCC.

Highlights

  • The development of hepatocellular carcinoma (HCC) is a major complication of viral infection induced by hepatitis virus C [1,2]

  • Since the hepatoma-derived cell line Huh-7 autonomously proliferates under serum-free conditions in vitro, we hypothesized the presence of an unknown growth factor in the conditioned medium and succeeded in purifying a new molecule, “hepatoma-derived growth factor (HDGF)” [8,9]

  • HDGF stimulates the proliferation of hepatoma cells in vitro [10,11], and the HDGF expression is significantly higher in human HCC tissues than in adjacent non-cancerous liver tissues [12]

Read more

Summary

Introduction

The development of hepatocellular carcinoma (HCC) is a major complication of viral infection induced by hepatitis virus C [1,2]. HDGF stimulates the proliferation of hepatoma cells in vitro [10,11], and the HDGF expression is significantly higher in human HCC tissues than in adjacent non-cancerous liver tissues [12]. HDGF expression is related to several unfavorable cancer characteristics, including rapid growth, significant invasiveness and metastasis, and it is associated with poor prognoses of various malignant diseases [13,14,15,16,17,18,19]. We initially identified HDGF as a growth-stimulating factor; HDGF has been reported to be an angiogenic factor and probable anti-apoptotic factor. This novel molecule may participate in the development and progression of many types of cancer through multiple mechanisms.

HDGF as a Novel Unique Growth Factor
HDGF as an Angiogenic Factor
HDGF as a Possible Anti-Apoptotic Factor
HDGF as a Growth-Promoting Factor for HCC
Future Perspectives
Conclusions
Findings
Conflicts of Interest
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.